About Us

Nora brings a proven entrepreneurial and executive experience in the healthcare industry. She holds a M.Sc. in regenerative medicine from the Technion and is highly experienced in developing and leading development of nanofiber based medical devices, biomaterials, nanotechnology and regenerative medicine. Nora was among the finalists of the EU women innovators prize in 2019. In 2021, 2018 & 2017, she was included in Globes “Women of Influence” list. Nora co-founded the Arab-Women-in-Science NGO which promotes women in STEM.

Dr. Amir Bahar is a multidisciplinary entrepreneur and neuroscientist with over 25 years of experience in clinical and preclinical models of brain research and tissue engineering. Amir brings extensive experience in management of R&D, regulation, clinical operation, production under ISO13485 and operation in general, with a focus on degradable implants and nanofibers. He is highly experienced in leading early and advanced R&D and clinical projects in medical devices, degradable implants and nanofibers. Amir received his Ph.D. in neurobiology from the Weizmann Institute and won a NARSAD Young Investigator Award (2008).

Hannoch Marksheid is a seasoned manager, with over 25 years of experience in managing entrepreneurial ventures in multi-cultural environments including biotechnological startups. Hannoch brings extensive experience in senior and executive management, fundraising, and global business development. He is an expert in strategic planning, process implementation and program development with extensive experience in fundraising from angels, corporates, corporate funds, and the venture capital community, as well as in raising non-diluting grants and debt instruments. Hannoch holds a PhD in economics and business management.

Mira brings nearly 25 years of executive financial management experience, served as chief financial officer of Check-Cap Ltd. (Nasdaq: CHCK).
Prior to Check-Cap, Ms. Rosenzweig served in various finance roles including CFO of Entera Bio Ltd. (Nasdaq: ENTX), vice president and chief financial officer of Camtek Ltd. (Nasdaq: CAMT) and director of finance at Elron Electronic Industries Ltd. (TASE: ELRN). Ms. Rosenzweig began her career as a senior accountant at Luboshitz Kasierer, which is now part of Ernst & Young. Mira holds a Bachelor of Arts in Accounting and Economics from the University of Haifa, and is a certified public accountant.

Ryan is a highly experienced medical device leader, recognized for building collaborative teams, establishing strong hospital partnerships, and developing effective commercial strategies. He has a proven track record in product launches, market development, and building strong healthcare partnerships. He leads the company’s commercial strategy and supports growth across the United States.Most recently, Ryan was a Director at GE Healthcare’s Surgical Visualization and Guidance unit, where he led the launch and integration of intraoperative ultrasound systems for neurosurgical and spine procedures in leading US hospitals. Prior to that, at Integra LifeSciences, he increased adoption of neurosurgical products by collaborating with key opinion leaders, strengthening hospital partnerships, and building high-performing teams. Earlier in his career, Ryan served as a Director at Novadaq, now part of Stryker, where he led commercial start-up efforts that expanded the US fluorescence imaging market, enabling surgeons to assess blood flow in real time and improve outcomes in minimally invasive, reconstructive, and transplant surgeries.
 

Dr. Koby Gvili is a biomaterial expert with extensive experience in R&D and Operations positions in medical device companies developing: cartilage and bone regeneration hydrogel, transgenic collagen, and dermal fillers. As the CEO of a project management company, Dr. Gvili managed over 40 projects for the biomedical industry in Israel and abroad in numerous fields including regenerative medicine, cardiology, diabetes, gynecology, drug and cannabinoid delivery. Koby holds a B.Sc.in Chemical Engineering (BGU university) and a Ph.D. in Biotechnology Engineering (Technion), focused on nanoparticle-based DNA vaccination.

Sagi is a multidisciplinary operations and technology executive with over 25 years of experience leading medical-device scale-up, commercialization, and global manufacturing. He brings a strong track record in building high-performing teams, establishing GMP-ready infrastructures, and driving supply chain, quality, and production strategies that support market growth. With experience across startups and large organizations, Sagi has guided products through FDA/CE readiness, process optimization, and commercial delivery. He holds an Executive MBA from Tel Aviv University and has led operations across the US, EU, and Asia.

Michal is a senior HR executive with extensive experience leading global HR organizations in complex, international environments. She combines strategic leadership with hands-on execution and has a proven track record in building HR infrastructures, supporting scale-up, M&A, and major organizational change.
She has held VP-level HR leadership roles at global technology and industrial companies including Augury, Marvell, Radware, and HP Indigo, partnering closely with CEOs and executive teams across fast-growing and regulated environments.
In addition, Michal works as an executive coach and organizational consultant, supporting leaders and organizations through growth, transformation, and complexity.

Amirit brings extensive experience across a wide range of medical device products and industries - from implantable devices and biomaterials to complex multidisciplinary systems combining software, hardware, and electronics. She has led global quality and regulatory programs at GE Healthcare and Medtronic, and later gained cross-industry insights through leadership roles at HP.

Rachel Leibovitze is a seasoned business development and strategy consultant, with extensive experience in market analysis, strategy creation and business development. She has worked with many biotech and medical device companies, helping them formulate their go to market strategies and gain in depth understanding of the competitive environment. As former BD manager at a biotech startup, she has experience in identifying potential strategic partners and building collaboration relationships. Rachel holds a BA in economics and business management from Bar Ilan University and an MBA from Tel Aviv University.